PsychoGenics is a pioneering preclinical CRO, and we are proud to offer advanced support for our partners at the forefront of emerging therapy research. With our deep expertise and commitment to advancing scientific innovation, we offer comprehensive capabilities across a broad range of therapeutic areas.
Support for Your Emerging Therapy Research Needs
PsychoGenics is dedicated to continuously developing and advancing services, techniques, and skills to support the evolving needs of emerging therapy studies.
Our industry-leading experience with rodent disease models and our pioneering In Vivo AI platforms allow us to provide support and insights for your novel therapy.
Our entire service catalog, comprising a wide array of analytical techniques and disease models, is available to advance the development and understanding of the next generation of CNS therapies.
Explore our emerging therapies capabilities: